Dr. Benjamin Murdock received his PhD in Immunology from the University of Michigan, Ann Arbor Immunology Program in 2010 under the mentorship of Drs. Gary Huffnagle and Eric White. He subsequently joined the University of Michigan Division of Pulmonary and Critical Care Medicine to examine the role of the immune system in promoting and preventing chronic pulmonary lung infections.
Dr. Murdock joined the University of Michigan Neurology Department in 2014 and begun working with Dr. Eva Feldman and Dr. Stephen Goutman to examine immune mechanisms underlying neurodegeneration, particularly amyotrophic lateral sclerosis (ALS). Using both clinical samples and mouse models of disease, Dr. Murdock’s current research explores the role of specific immune populations in driving or protecting against ALS. His current projects focus on natural killer (NK) cells and the role of NK cells in exacerbating damage to motor neurons. In addition to his work in ALS, Dr. Murdock is also examining the role of the immune system diabetes, particularly the contribution of macrophages to diabetic neuropathy.
Areas of Interest
Amyotrophic lateral sclerosis, immunology, diabetic neuropathy, diabetic complications, clinical studies, mouse models of disease
Effective treatments for ALS have eluded scientists for decades. A new examination of the immune system led by Dr. Benjamin Murdock shows the appeal of personalized medicine for future care.
- PhD Immunology, University of Michigan, Ann Arbor, 2010
- NIH T32 Lung Immunopathology Training Grant, University of Michigan, Ann Arbor, 2010